| 2 | 1/1 | 返回列表 |
| 查看: 566 | 回復(fù): 1 | |||
wh168ren木蟲 (小有名氣)
|
[求助]
鹽酸利托君片質(zhì)量標(biāo)準(zhǔn)
|
| 中檢所進(jìn)口藥品復(fù)核標(biāo)準(zhǔn)(5)里的鹽酸利托君片。有的麻煩傳分,謝謝! |
木蟲 (著名寫手)
|
Ritodrine Hydrochloride Tablets » Ritodrine Hydrochloride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C17H21NO3·HCl. Packaging and storage— Preserve in tight containers. Store at room temperature, preferably below 30. USP Reference standards 11— USP Ritodrine Hydrochloride RS. Identification— The retention time of the Tablets in the Assay preparation obtained in the Assay corresponds to that of the Standard preparation obtained in the Assay. Dissolution 711— Medium: 0.01 N hydrochloric acid; 900 mL. Apparatus 2: 50 rpm. Time: 30 minutes. Procedure— Determine the amount of C17H21NO3·HCl dissolved by employing the procedure set forth in the Assay, using a filtered portion of the solution under test as the Assay preparation in comparison with a Standard solution having a known concentration of USP Ritodrine Hydrochloride RS in the same Medium. Tolerances— Not less than 80% (Q) of the labeled amount of C17H21NO3·HCl is dissolved in 30 minutes. Uniformity of dosage units 905: meet the requirements. Procedure for content uniformity— Transfer 1 Tablet to a 200-mL volumetric flask, add about 5 mL of water, and stir until disintegration is complete. Add about 150 mL of methanolic sulfuric acid solution (0.005 M sulfuric acid in methanol), continue stirring for an additional 15 minutes, dilute with methanolic sulfuric acid solution to volume, and mix. Filter a portion of the mixture, discarding the first 20 mL of the filtrate. Dissolve an accurately weighed quantity of USP Ritodrine Hydrochloride RS in methanolic sulfuric acid solution, and dilute quantitatively and stepwise with the same solvent to obtain a Standard solution having a known concentration of about 50 µg per mL. Concomitantly determine the absorbances of both solutions in 1-cm cells at the wavelength of maximum absorbance at about 276 nm, with a suitable spectrophotometer, using methanolic sulfuric acid solution as the blank. Calculate the quantity, in mg, of C17H21NO3·HCl in the Tablet taken by the formula: (TC / D)(AU / AS) in which T is the labeled quantity, in mg, of ritodrine hydrochloride in the Tablet, C is the concentration, in µg per mL, of USP Ritodrine Hydrochloride RS in the Standard solution, D is the concentration, in µg per mL, of ritodrine hydrochloride in the solution from the Tablet based upon the labeled quantity per Tablet and the extent of dilution, and AU and AS are the absorbances of the solution from the Tablet and the Standard solution, respectively. Assay— Mobile phase, Standard preparation, and System suitability preparation— Proceed as directed in the Assay under Ritodrine Hydrochloride. Assay preparation— Weigh and finely powder not less than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 20 mg of ritodrine hydrochloride, to a 100-mL volumetric flask. Add about 70 mL of Mobile phase, stir for about 15 minutes, dilute with Mobile phase to volume, mix, and filter a portion to remove any particulate matter. Chromatographic system— Proceed as directed in the Assay under Ritodrine Hydrochloride Injection. Procedure— Proceed as directed in the Assay under Ritodrine Hydrochloride. Calculate the quantity, in mg, of C17H21NO3·HCl in the portion of Tablets taken by the formula: 100C(rU / rS) in which the terms are as defined therein. Auxiliary Information— Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Daniel K. Bempong, Ph.D. Senior Scientist 1-301-816-8143 (MDPS05) Monograph Development-Pulmonary and Steroids Reference Standards Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org 711 Margareth R.C. Marques, Ph.D. Senior Scientist 1-301-816-8106 (BPC05) Biopharmaceutics05 USP32–NF27 Page 3519 Chromatographic Column— RITODRINE HYDROCHLORIDE TABLETS Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27. |

| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿985,本科211,0817化學(xué)工程與技術(shù)319求調(diào)劑 +10 | Liwangman 2026-03-15 | 10/500 |
|
|---|---|---|---|---|
|
[考研] 332求調(diào)劑 +3 | ydfyh 2026-03-17 | 3/150 |
|
|
[考研] 0703化學(xué)調(diào)劑,求各位老師收留 +10 | 秋有木北 2026-03-14 | 10/500 |
|
|
[考研] 298-一志愿中國(guó)農(nóng)業(yè)大學(xué)-求調(diào)劑 +7 | 手機(jī)用戶 2026-03-17 | 7/350 |
|
|
[考研] 0703化學(xué)調(diào)劑 ,六級(jí)已過(guò),有科研經(jīng)歷 +10 | 曦熙兮 2026-03-15 | 10/500 |
|
|
[考研] 0703化學(xué)調(diào)劑 +3 | 妮妮ninicgb 2026-03-17 | 3/150 |
|
|
[考研] 材料,紡織,生物(0856、0710),化學(xué)招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|
|
[考博] 26博士申請(qǐng) +3 | 1042136743 2026-03-17 | 3/150 |
|
|
[基金申請(qǐng)] 被我言中:新模板不強(qiáng)調(diào)格式了,假專家開(kāi)始管格式了 +4 | beefly 2026-03-14 | 4/200 |
|
|
[考研] 085601求調(diào)劑 +4 | Du.11 2026-03-16 | 4/200 |
|
|
[考研] 考研調(diào)劑 +3 | 淇ya_~ 2026-03-17 | 5/250 |
|
|
[考研] 278求調(diào)劑 +3 | Yy7400 2026-03-13 | 3/150 |
|
|
[考研]
|
zhouzhen654 2026-03-16 | 3/150 |
|
|
[考研] 藥學(xué)383 求調(diào)劑 +3 | 藥學(xué)chy 2026-03-15 | 4/200 |
|
|
[考研] 333求調(diào)劑 +3 | 文思客 2026-03-16 | 7/350 |
|
|
[考研] 085600調(diào)劑 +5 | 漾漾123sun 2026-03-12 | 6/300 |
|
|
[考研] 085601材料工程315分求調(diào)劑 +3 | yang_0104 2026-03-15 | 3/150 |
|
|
[考研] 266求調(diào)劑 +4 | 學(xué)員97LZgn 2026-03-13 | 4/200 |
|
|
[考研] 求材料調(diào)劑 085600英一數(shù)二總分302 前三科235 精通機(jī)器學(xué)習(xí) 一志愿哈工大 +4 | 林yaxin 2026-03-12 | 4/200 |
|
|
[考研] 290求調(diào)劑 +3 | ADT 2026-03-13 | 3/150 |
|